Pyoderma Gangrenosum Fails Initial Treatment Plans
Photo Clinic: A case of pyoderma gangrenosum that failed antibiotics, steroids, other immunosuppressive agents, thalidomide and cyclosporine.
A Weeping Wound with Ragged Edges and a Putrid Odor
Case Study: A female patient presents with a case of pyoderma gangrenosum that fails multiple standard treatments.
A Long and Winding Road Ahead in Personalized Medicine
Genetics research shows great promise for personalized treatment in rheumatology — but diagnostic and prognostic gene tests are years away.
Methotrexate Dosing Re-Examined with Certolizumab Pegol
Certolizumab pegol reduces the signs and symptoms of rheumatoid arthritis regardless of how much methotrexate is prescribed, study shows.
Stopping Biologic Therapy in RA Could Trigger Flares
While there are many studies that examine how well TNFi biologic therapies work in rheumatoid arthritis, few studies have examined when TNFi can be safely stopped, until now.
Belimumab: Groundbreaker in Lupus
Belimumab has been a ground-breaking therapy for patients with systemic lupus erythematosus. In this op-ed, Paul Sufka, M.D., reviews recent studies on belimumab which could lead to new uses.
Abatacept and Glucocorticoids as One Could be a Combo Worth Exploring
A new report suggests that reducing or stopping glucocorticoid therapy can be achieved safely with intravenous abatacept.
"No Safe Dose in Glucocorticoids"
Eric Morand, M.D., Ph.D., Director of Rheumatology at Monash Health in Australia, speaks with Rheumatology Network about his recent article in Nature Reviews Rheumatology.
IL-12 and IL-23 Therapeutic Targets Reviewed
Researchers have clarified the contribution of IL-12 and IL-23 in immune regulation.
IL-17, IL-23 Psoriasis Pathway Inhibitors
The development pipeline for psoriasis in summary.